THX Pharma Société Anonyme (ALTHX)
Euronext
Closed
Oct 7, 2026
Day's Range
3.2552 wk Range
1.49Overview - ALTHX - THX Pharma Société Anonyme
Key Statistics
Valuation
Enterprise Value
38.71M
P/E (Forward)
-1.71
PEG Ratio
-1.71
Price / Sales (TTM)
56.80
Price / Book
15.04
EV / EBITDA
-9.82
Profitability
Profit Margin
0.00%
Operating Margin
-144,876,610.00%
Return on Assets
-35.42%
Return on Equity
-482.39%
Ownership
Shares Outstanding
13.76M
Float
13.13M
Held by Insiders
12.84%
Held by Institutions
19.71%
Price stats
Beta
1.51
50-Day Avg
3.91
200-Day Avg
3.30
Dividends
Payout Ratio
0.00%
Analyst Consensus
1 analysts
Market Cap - ALTHX - THX Pharma Société Anonyme
Peers - ALTHX - THX Pharma Société Anonyme
Peer Comparison
Compared with companies in Biotechnology listed on Euronext.
Profile Summary - ALTHX - THX Pharma Société Anonyme
About
THX Pharma Société Anonyme is a French biopharmaceutical company focused on developing treatments for rare neurological diseases and central nervous system disorders. The company works on drug candidates designed to address conditions with limited therapeutic options, with a particular emphasis on innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
